Semaglutide in India — drug-class guide
Short answer
Semaglutide is a GLP-1 receptor agonist approved in India for type 2 diabetes and chronic weight management. Available as weekly injection and daily oral tablet. Generic versions have reduced costs since 2024. Requires prescription and CDSCO-approved sourcing.
What is semaglutide?
Semaglutide is a long-acting GLP-1 receptor agonist that improves HbA1c, reduces appetite, and supports weight loss. It is a drug class molecule — not a single brand. CDSCO has approved it for specified indications under physician supervision.
Injectable vs oral semaglutide
Weekly subcutaneous injection is the most established form. Oral semaglutide (daily tablet on empty stomach) suits injection-averse patients but has stricter timing rules. Efficacy is broadly similar at equivalent doses in trials.
Generic semaglutide in India
Following patent developments, CDSCO-approved generic semaglutide from licensed Indian manufacturers offers lower monthly costs. Verify bioequivalence, batch numbers, and cold-chain handling — not social-media sellers.
Who prescribes semaglutide in Indian practice
Endocrinologists, internal medicine specialists, and cardiologists with metabolic expertise commonly initiate GLP-1 therapy when RSSDI and ICMR criteria are met. Diabetologists and some bariatric physicians also prescribe within their scope. Your primary care physician may refer you when BMI, HbA1c, or comorbidity patterns warrant specialist input.
CDSCO approval and Schedule H rules
Semaglutide is a Schedule H prescription medicine in India. Purchase only from licensed pharmacies with valid prescriptions. Package inserts list approved indications—using semaglutide outside physician-directed indications carries medical and legal risk. Cross-check product names against CDSCO approved drug lists quarterly as generics enter the market.
Semaglutide vs other GLP-1 drug classes
Semaglutide is one molecule within the broader GLP-1 receptor agonist class. Tirzepatide adds GIP activity; liraglutide requires daily injection. Your doctor selects based on glycaemic targets, weight goals, side-effect tolerance, kidney function, and monthly budget—not social media brand rankings. Kesho compares drug classes without promoting any manufacturer.
Storage and travel for Indian patients
Unopened semaglutide pens require refrigeration at 2–8°C. After first use, most products tolerate room temperature up to 30°C for several weeks—critical during Indian summers. Use insulated travel cases on trains and flights. Never use pens that were warm for extended periods or past in-use expiry dates printed on the label.
HbA1c and weight monitoring on semaglutide
RSSDI follow-up typically includes HbA1c every three months during titration, then every six months at maintenance if targets are met. Weight and waist circumference track monthly at home. Indian patients with fatty liver or prediabetes may need additional liver enzyme panels. Bring logs to every consultation—structured data improves dose decisions.
Ayurveda and supplement interactions
Inform your physician about ayurvedic diabetes or weight products—some contain hidden metformin-like compounds or stimulants that interact with appetite suppression. Protein supplements are generally safe but do not replace meals during severe nausea. Turmeric and fenugreek in normal dietary amounts rarely conflict; concentrated extracts need medical review.
Complete semaglutide guide on Kesho
Our cornerstone semaglutide guide covers CDSCO status, oral versus injectable forms, generic pricing, safety, and doctor preparation in 3,800+ words with references. This landing page summarises search intent; the full guide provides evidence rails and FAQ schema for deeper reading. Markdown alternate available for research agents.
Questions to ask your prescriber
Ask about titration schedule, expected HbA1c target, monthly cost range at maintenance, storage during summer travel, symptoms requiring urgent contact, and generic alternatives if budget tightens. Frame questions around the semaglutide drug class—not a brand seen on social media. Request follow-up appointment before leaving if therapy starts.
Semaglutide in elderly Indian patients
Frail elderly patients require cautious assessment—excessive weight loss may worsen sarcopenia and fall risk. Kidney function declines with age; dosing adjusts accordingly. Polypharmacy is common; review all medicines including ayurvedic preparations before starting. Family caregivers should attend consultations to understand injection technique and warning signs.
Festival and wedding season eating
Indian social calendars centre on shared meals during Diwali, Eid, and weddings. Semaglutide reduces appetite but does not eliminate social pressure to eat. Plan smaller portions, prioritise protein, and avoid greasy mithai during titration when nausea peaks. Discuss temporary dose timing adjustments with your physician for multi-day events—not unsupervised skipping.
When semaglutide is not the first choice
Severe gastroparesis, active pregnancy planning, MTC/MEN2 history, or type 1 diabetes exclude semaglutide use. Some patients prefer daily liraglutide for finer dose control despite injection frequency. Cost may favour generic semaglutide over oral forms at equivalent exposure—pharmacy quotes determine practical choice.
Renal dosing considerations
Semaglutide dosing may adjust in advanced kidney disease—bring creatinine and eGFR results to consultations. RSSDI guidance emphasises individualised targets in diabetic kidney disease. Never alter dose based on online charts without physician confirmation. Kidney monitoring continues quarterly during first year of therapy for high-risk patients. Discuss dialysis timing if eGFR is declining.
Quick questions
Is Semaglutide in India information on Kesho medical advice?
Where is the full guide?
What is the short answer on semaglutide in india?
Related guides
SafetyIs Semaglutide Safe in India? What Patients Should Know
Semaglutide dominates headlines for weight loss and diabetes control—but safety questions matter as much as results. For Indian patients navigating social-media hype, generic launches, and prescription-only rules, understanding evidence-based safety helps you use this GLP-1 receptor agonist responsibly under medical care.
Read guide →
BasicsOral Semaglutide in India: What Patients Should Know
Not everyone wants weekly injections. Oral semaglutide brings GLP-1 receptor agonist therapy to a daily tablet—with strict morning rules that conflict with Indian bed tea, haldi doodh, and early breakfast habits. Understanding absorption requirements, cost reality versus injectable generics, and who truly benefits from tablets versus pens helps you discuss format choice with your endocrinologist rather than assuming pills are easier or cheaper by default.
Read guide →BasicsOral vs Injectable Semaglutide in India: Which Form Fits You?
Semaglutide arrives in Indian clinics as a weekly pen and as a daily tablet—same GLP-1 receptor agonist, very different routines. Patients often ask which form is "better," but the honest answer depends on adherence, lifestyle, clinical goals, and cost in your city—not a universal winner.
Read guide →
Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 15, 2026